The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity

The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity

Conventional dendritic cells (cDCs) orchestrate immune responses to cancer and comprise two major subsets: type-1 cDCs (cDC1s) and type-2 cDCs (cDC2s). Compared with cDC1s, which are dedicated to the activation of CD8<sup>+</sup> T cells, cDC2s are ontogenically and functionally heteroge...

Full description

Bibliographic Details
Main Authors:	Yasuyuki Saito, Satomi Komori, Takenori Kotani, Yoji Murata, Takashi Matozaki
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Cancers
Subjects:	type-2 conventional dendritic cell tumor immunity antigen presentation DC vaccine
Online Access:	https://www.mdpi.com/2072-6694/14/8/1976

Similar Items

Harnessing Dendritic Cells for Tumor Antigen Presentation
by: Stefan Nierkens, et al.
Published: (2011-04-01)

Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
by: Jianmei W. Leavenworth, et al.
Published: (2022-09-01)

Dendritic cells in cancer immunotherapy clinical trials: are we making progress?
by: Lisa Helene Butterfield
Published: (2013-12-01)

A Discrete Subset of Monocyte-Derived Cells among Typical Conventional Type 2 Dendritic Cells Can Efficiently Cross-Present
by: Sheng, Jianpeng, et al.
Published: (2018)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
by: Shinji Morisaki, et al.
Published: (2023-10-01)

Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01)

Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells
by: Eduardo I. Tognarelli, et al.
Published: (2019-04-01)

GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2
by: Seyed Mohammad Lellahi, et al.
Published: (2023-01-01)

Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review
by: Dong Wang, et al.
Published: (2022-11-01)

Insights into dendritic cell maturation during infection with application of advanced imaging techniques
by: Qi Xiao, et al.
Published: (2023-03-01)

Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)
by: Masanori Oshi, et al.
Published: (2020-11-01)

Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
by: Kyu-Won Lee, et al.
Published: (2023-08-01)

Conventional dendritic cell 2 links the genetic causal association from allergic asthma to COVID-19: a Mendelian randomization and transcriptomic study
by: Hua Liu, et al.
Published: (2024-02-01)

Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers
by: Hongtai Xiong, et al.
Published: (2023-10-01)

OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cells
by: Sebastian Wirsching, et al.
Published: (2022-09-01)

Magnetic nanoparticles enhance the cellular immune response of dendritic cell tumor vaccines by realizing the cytoplasmic delivery of tumor antigens
by: Linghong Huang, et al.
Published: (2023-03-01)

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
by: Ichwaku Rastogi, et al.
Published: (2023-12-01)

Impaired function of dendritic cells within the tumor microenvironment
by: Zhihua Xiao, et al.
Published: (2023-06-01)

Dendritic cell therapy for cancers and underlying mechanisms involved in cancer development
by: Thi Xuan Nguyen, et al.
Published: (2017-06-01)

The functional role of L-fucose on dendritic cell function and polarization
by: Chase Burton, et al.
Published: (2024-04-01)

Research Progress of Dendritic Cell Surface Receptors and Targeting
by: Chunyu Tong, et al.
Published: (2023-06-01)

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment
by: Daniela A. Bota, et al.
Published: (2022-12-01)

Variability in the virulence of specific Mycobacterium tuberculosis clinical isolates alters the capacity of human dendritic cells to signal for T cells
by: Ana Gabriela Ramos-Martinez, et al.

Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies
by: Takuya Sakamoto, et al.
Published: (2022-07-01)

Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer
by: Enrica Marmonti, et al.
Published: (2022-09-01)

Self-antigen presentation by dendritic cells in autoimmunity
by: Ann-Katrin eHopp, et al.
Published: (2014-02-01)

CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine
by: Maud Plantinga, et al.
Published: (2021-07-01)

The rise of Candida auris: from unique traits to co-infection potential
by: Haiheng Xu, et al.
Published: (2022-08-01)

Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors
by: Maud Plantinga, et al.
Published: (2019-02-01)

Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target
by: Jiaxin Li, et al.
Published: (2023-02-01)

Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines
by: Irene Fernández-Delgado, et al.
Published: (2020-11-01)

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
by: João Calmeiro, et al.
Published: (2020-02-01)

Enhancing Protective Efficacy of Poultry Vaccines through Targeted Delivery of Antigens to Antigen-Presenting Cells
by: Angita Shrestha, et al.
Published: (2018-11-01)

Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
by: Christian H. K. Lehmann, et al.
Published: (2016-03-01)

An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer
by: Yunting Zhang, et al.
Published: (2023-08-01)

Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery
by: Aleksandar Murgaski, et al.
Published: (2019-05-01)

Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
by: Aarushi Audhut Caro, et al.
Published: (2022-08-01)

Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization
by: Nai-Yun Sun, et al.
Published: (2019-09-01)

Cross-Presenting XCR1<sup>+</sup> Dendritic Cells as Targets for Cancer Immunotherapy
by: Katherine M. Audsley, et al.
Published: (2020-02-01)

Human dendritic cell targeting peptide can be targeted to porcine dendritic cells to improve antigen capture efficiency to stimulate stronger immune response
by: Tian Xia, et al.
Published: (2022-08-01)